iSpecimen Inc. (ISPC) vs T2 Biosystems, Inc. (TTOO)
- iSpecimen Inc. ISPC 0.92 −10.68%
- T2 Biosystems, Inc. TTOO 0.00 NaN
iSpecimen Inc. and T2 Biosystems, Inc. are both Diagnostics & Research companies. T2 Biosystems, Inc. is the larger, with a market value of $6.5M against $2.6M — 2.5× the size. T2 Biosystems, Inc. grew revenue faster over the last twelve months: −30.2% against −92.1%. T2 Biosystems, Inc. has the higher net margin (−559.5% vs −2,449.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, T2 Biosystems, Inc. leads on 12 and iSpecimen Inc. on 2.
Valuation
Profitability
| Metric | ISPC | TTOO | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | (108.26%) | (76.76%) | 50.89% |
| Operating margin | (2,020.05%) | (542.59%) | (8.57%) |
| Net margin | (2,449.02%) | (559.52%) | (6.37%) |
| Free cash flow margin | (1,866.61%) | (476.64%) | 0.00% |
| Return on equity | (968.44%) | 277.61% | (2.92%) |
| Return on assets | (170.09%) | (140.00%) | (6.71%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack